Please ensure Javascript is enabled for purposes of website accessibility

Dividend Aristocrat AbbVie Declares Its Latest Payout; Yield Is 5.3%

By Eric Volkman – Sep 11, 2020 at 8:26PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company is one of the most solid dividend dispensers in its industry.

One of the top dividend stocks in the healthcare sector is getting ready to hand out some cash to shareholders yet again. AbbVie (ABBV 0.36%) announced Friday that its board of directors has declared a fresh quarterly dividend of $1.18 per share.

This is to be distributed on Nov. 16 to investors of record as of Oct. 15. On Friday's closing share price, it would yield just under 5.3%. That's generous relative to the overall healthcare industry, in which dividends tend to be the exception rather than the rule. It also compares favorably to the yields of many blue chip stocks favored by dividend stock investors.

Person putting a card reading DIVIDENDS into their suit breast pocket.

Image source: Getty Images.

AbbVie has been a steady dividend payer and lifter since it was spun off from Abbott Laboratories (ABT -1.51%) in 2013. Since Abbott is a Dividend Aristocrat (an S&P 500 index component that has increased its payout at least once every year for a minimum of 25 consecutive years), AbbVie is considered one too. Abbott has consistently lifted dividends for almost 50 years.

AbbVie last raised its payout in November 2019 with a 10% hike. As its declarations are made quarterly, we can assume its next announcement will also herald an increase.

Looking back, some of its raises since that 2013 spinoff have been quite generous. All told, dividend stock aficionados have done well with the company; from spinoff until the present, the payout has nearly tripled from $0.40 per share to the current amount.

On Friday, AbbVie shares traded essentially sideways, more or less in step with the development of the wider stock market.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

AbbVie Inc. Stock Quote
AbbVie Inc.
$141.72 (0.36%) $0.51
Abbott Laboratories Stock Quote
Abbott Laboratories
$98.33 (-1.51%) $-1.51

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.